Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Friday's Pre-Market Session

Author: Benzinga Insights | February 07, 2025 07:05am

Gainers

  • Universe Pharmaceuticals (NASDAQ:UPC) shares moved upwards by 67.7% to $0.27 during Friday's pre-market session. The company's market cap stands at $2.3 million.
  • Doximity (NYSE:DOCS) stock moved upwards by 24.42% to $72.49. The company's market cap stands at $13.5 billion. As per the news, the Q3 earnings report came out yesterday.
  • Nutriband (NASDAQ:NTRB) stock increased by 16.49% to $7.77. The market value of their outstanding shares is at $86.2 million.
  • Helius Medical Tech (NASDAQ:HSDT) stock rose 15.25% to $0.68. The company's market cap stands at $2.5 million.
  • FibroBiologics (NASDAQ:FBLG) stock increased by 14.37% to $1.83. The company's market cap stands at $64.4 million.
  • TNF Pharmaceuticals (NASDAQ:TNFA) stock moved upwards by 8.62% to $0.65. The company's market cap stands at $1.7 million.

Losers

  • Fractyl Health (NASDAQ:GUTS) stock decreased by 24.2% to $1.22 during Friday's pre-market session. The company's market cap stands at $58.6 million.
  • Neuronetics (NASDAQ:STIM) shares declined by 21.92% to $2.78. The company's market cap stands at $154.7 million.
  • Alumis (NASDAQ:ALMS) stock fell 16.55% to $5.5. The market value of their outstanding shares is at $299.2 million.
  • Exicure (NASDAQ:XCUR) stock fell 13.57% to $9.94. The market value of their outstanding shares is at $30.2 million.
  • Lipella Pharmaceuticals (NASDAQ:LIPO) stock fell 12.26% to $4.08. The market value of their outstanding shares is at $4.9 million.
  • Neurocrine Biosciences (NASDAQ:NBIX) stock declined by 11.65% to $132.98. The market value of their outstanding shares is at $13.4 billion. As per the press release, Q4 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ALMS DOCS FBLG GUTS HSDT LIPO NBIX NTRB STIM TNFA UPC XCUR

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist